Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 18
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Takla, A Wichmann, O Hautmann, W and Rieck, T 2013. Mumps epidemiology in Germany 2007-11. Eurosurveillance, Vol. 18, Issue. 33, p. 20557.


    Park, Sun Hee 2015. Resurgence of Mumps in Korea. Infection & Chemotherapy, Vol. 47, Issue. 1, p. 1.


    Yitshak-Sade, Maayan Davidovitch, Nadav Novack, Lena and Grotto, Itamar 2016. Ethnicity and immunization coverage among schools in Israel. Ethnicity & Health, Vol. 21, Issue. 5, p. 439.


    Fiebelkorn, Amy Parker Lawler, Jacqueline Curns, Aaron T. Brandeburg, Christina and Wallace, Gregory S. 2013. Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA. Emerging Infectious Diseases, Vol. 19, Issue. 9, p. 1411.


    Abrams, S. Beutels, P. and Hens, N. 2014. Assessing Mumps Outbreak Risk in Highly Vaccinated Populations Using Spatial Seroprevalence Data. American Journal of Epidemiology, Vol. 179, Issue. 8, p. 1006.


    Zamir, C Stein Schroeder, H Shoob, H Abramson, N and Zentner, G 2015. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Human Vaccines & Immunotherapeutics, Vol. 11, Issue. 6, p. 1413.


    Santacruz-Sanmartín, Eduardo Hincapié-Palacio, Doracelly Ospina, Marta C. Perez-Toro, Olga Bernal-Restrepo, Luz M. Buitrago-Giraldo, Seti Lenis-Ballesteros, Viviana and Díaz, Francisco J. 2015. Seroprevalence of mumps in an epidemic period in Medellín, Colombia. Vaccine, Vol. 33, Issue. 42, p. 5606.


    Takla, Anja Böhmer, Merle M Klinc, Christina Kurz, Norbert Schaffer, Alice Stich, Heribert Stöcker, Petra Wichmann, Ole and Koch, Judith 2014. Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Human Vaccines & Immunotherapeutics, Vol. 10, Issue. 1, p. 140.


    Kutty, Preeta Krishnan Lawler, Jacqueline Rausch-Phung, Elizabeth Ortega-Sanchez, Ismael R Goodell, Stephen Schulte, Cynthia Pollock, Lynn Valure, Barbara Hudson, Jean Gallagher, Kathleen and Blog, Debra 2014. Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009–2010. Human Vaccines & Immunotherapeutics, Vol. 10, Issue. 5, p. 1373.


    Anis, Emilia Grotto, Itamar Moerman, Larisa Kaliner, Ehud Warshavsky, Bruce Slater, Paul E and Lev, Boaz 2013. Rubella in Israel after the MMR vaccine: Elimination or containment?. Journal of Public Health Policy, Vol. 34, Issue. 2, p. 288.


    Jin, Li Örvell, Claes Myers, Richard Rota, Paul A. Nakayama, Tetsuo Forcic, Dubravko Hiebert, Joanne and Brown, Kevin E. 2015. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Reviews in Medical Virology, Vol. 25, Issue. 2, p. 85.


    Vygen, Sabine Fischer, Aurélie Meurice, Laure Mounchetrou Njoya, Ibrahim Gregoris, Marina Ndiaye, Bakhao Ghenassia, Adrien Poujol, Isabelle Stahl, Jean Paul Antona, Denise Le Strat, Yann Levy-Bruhl, Daniel and Rolland, Patrick 2016. Waning immunity against mumps in vaccinated young adults, France 2013. Eurosurveillance, Vol. 21, Issue. 10,


    2013. Falldefinitionen zur Übermittlung von Erkrankungs- und Todesfällen sowie von Erregernachweisen von Mumps, Pertussis, Röteln und Varizellen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 56, Issue. 7, p. 1003.


    Parker Fiebelkorn, Amy Rosen, Jennifer B. Brown, Cedric Zimmerman, Christopher M. Renshowitz, Hyman D'Andrea, Christopher Gallagher, Kathleen M. Harpaz, Rafael and Zucker, Jane R. 2013. Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009–2010. Human Vaccines & Immunotherapeutics, Vol. 9, Issue. 1, p. 189.


    Kang, Ha Ra Kim, Sung Yoon Cha, Hyo Hyun An, Young Min Park, In Ah Kang, Hae Ji and Eun, Byung Wook 2015. An Outbreak of Mumps in a High School, Seoul, 2013. Pediatric Infection and Vaccine, Vol. 22, Issue. 1, p. 1.


    Tafuri, Silvio Gallone, Maria Serena Larocca, Angela Maria Vittoria and Germinario, Cinzia 2016. How will the MMR universal mass vaccination change the epidemiologic pattern of mumps? A 2012 Italian serosurvey. American Journal of Infection Control,


    Hukic, M Hajdarpasic, A Ravlija, J Ler, Z Baljic, R Dedeic Ljubovic, A Moro, A Salimović-Besic, I Sausy, A Muller, C and Hübschen, J 2014. Mumps outbreak in the Federation of Bosnia and Herzegovina with large cohorts of susceptibles and genetically diverse strains of genotype G, Bosnia and Herzegovina, December 2010 to September 2012. Eurosurveillance, Vol. 19, Issue. 33, p. 20879.


    Barskey, Albert E. Schulte, Cynthia Rosen, Jennifer B. Handschur, Elizabeth F. Rausch-Phung, Elizabeth Doll, Margaret K. Cummings, Kisha P. Alleyne, E. Oscar High, Patricia Lawler, Jacqueline Apostolou, Andria Blog, Debra Zimmerman, Christopher M. Montana, Barbara Harpaz, Rafael Hickman, Carole J. Rota, Paul A. Rota, Jennifer S. Bellini, William J. and Gallagher, Kathleen M. 2012. Mumps Outbreak in Orthodox Jewish Communities in the United States. New England Journal of Medicine, Vol. 367, Issue. 18, p. 1704.


    ×

Mumps outbreak in Israel's highly vaccinated society: are two doses enough?

  • E. ANIS (a1) (a2), I. GROTTO (a1) (a3), L. MOERMAN (a1), B. WARSHAVSKY (a1), P. E. SLATER (a1) (a2) and B. LEV (a1)
  • DOI: http://dx.doi.org/10.1017/S095026881100063X
  • Published online: 20 April 2011
Abstract
SUMMARY

Mumps outbreaks in recent years have given rise to questions about the effectiveness of the mumps vaccine. This study examined the epidemiological data from a recent mumps outbreak in Israel and from outbreaks in other countries with high vaccination coverage, and considered whether long-established vaccination policies designed to protect against mumps are in need of revision. Of over 5000 case patients in the Israeli outbreak, half of whom were in the Jerusalem health district, nearly 40% were aged ⩾15 years and, of those whose vaccination status was known, 78% had been fully vaccinated for their age – features similar to those in recent mumps outbreaks in Europe and North America. The epidemiological and laboratory evidence suggests that many previously vaccinated adolescents and young adults are now susceptible to mumps because their vaccine-based immunity has waned. Booster vaccination programmes for those at high risk of infection during mumps outbreaks – particularly those in congregate living environments – merit priority consideration.

Copyright
Corresponding author
*Author for correspondence: E. Anis, MD, MPH, Director, Division of Epidemiology, Ministry of Health, Israel. (Email: emilia.anis@moh.health.gov.il)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.PE Slater , E Anis , A Leventhal . The control of mumps in Israel. European Journal of Epidemiology 1999; 15: 765787.

3.E Anis , Measles in a highly vaccinated society: the 2007–2008 outbreak in Israel. Journal of Infection 2009; 59: 252258.

4.GH Dayan , S Rubin . Mumps Outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clinical Infectious Diseases 2008; 47: 14581467.

5.JM Conly , BL Johnston . Is mumps making a comeback? Canadian Journal of Infectious Diseases & Medical Microbiology 2007; 18: 79.

6.AE Barskey , JW Glasser , CW LeBaron . Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009; 27: 61866195.

8.E Savage , Mumps outbreaks across England and Wales in 2004: observational study. British Medical Journal 2005; 330: 11191120.

13.JD Shanley . The resurgence of mumps in young adults and adolescents. Cleveland Clinic Journal of Medicine 2007; 74: 4248.

16.ES McBryde . Network structure can play a role in vaccination thresholds and herd immunity: a simulation using a network mathematical model. Clinical Infectious Diseases 2009; 48: 685686.

17.C Cohen , Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerging Infectious Diseases 2007: 13(1).

21.GH Dayan , Recent resurgence of mumps in the United States. New England Journal of Medicine 2008; 358: 15801589.

22.G Watson-Creed , Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Canadian Medical Association Journal 2006; 175: 483488.

23.VS Kancherla , IC Hanson . Mumps resurgence in the United States. Journal of Allergy and Clinical Immunology 2006; 118: 938941.

24.LJ Anderson , JF Seward . Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatric Infectious Disease Journal 2008; 27 (10 Suppl.): S75S79.

25.PA Briss , Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. Journal of Infectious Diseases 1994; 169: 7782.

26.H Peltola , Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clinical Infectious Diseases 2007; 45: 459466.

28.MM Cortese , Mumps vaccine performance among university students during a mumps outbreak. Clinical Infectious Diseases 2008; 46: 11721180.

29.SA Rubin , Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. Journal of Infectious Diseases 2008; 198: 505515.

31.AA Date , Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. Journal of Infectious Diseases 2008; 197: 16621668.

32.PK Kutty , Seroprevalence of antibody to mumps virus in the US population, 1999–2004. Journal of Infectious Diseases 2010; 202: 667674.

33.DW Park , Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 2007; 25: 46654670.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: